We detected strong p-STAT3 expression in tumor-infiltrating CD19+ B cells, CD4+ T cells, and CD8+ T cells only in post PARPi therapy samples but not in their counterparts before PARPi treatment (Figures 3A–C). Here, STAT3 is linked to neoplasm.